Until now, the window to treat acute stroke with tissue plasminogen activator (tPA) or endovascular thrombectomy was six hours, maximum. Many centers wouldn’t administer tPA after four hours.
Explore This IssueACEP Now: Vol 37 – No 04 – April 2018
Although many emergency physicians can attest to the professional satisfaction of successfully administering treatment to a patient who otherwise would have had a lifelong, debilitating neurologic deficit, most can also point to the intense frustration felt when a patient presented with a stroke that fell outside the treatment window. The treatment time limit cruelly limited the number of patients who could regain the ability to move or speak.
Progress has been made in the implementation of operational efficiencies to facilitate the early, prehospital identification of stroke symptoms; rapid EMS stroke diagnosis; rapid CT imaging; and, if appropriate, the timely administration of tPA and thrombectomy. However, the six hour problem remained—endovascular thrombectomy was previously recommended only if performed within six hours of symptom onset.
But we have good news: With the recent publications of the DAWN and DEFUSE3 trials, there’s new hope.
The DAWN trial demonstrated that select patients with acute ischemic stroke presenting from 6–24 hours of symptom onset have improved 90-day outcomes after mechanical thrombectomy compared to medical therapy alone.1
The DEFUSE3 trial showed similar results of improved outcomes with endovascular thrombectomy for ischemic stroke patients 6–16 hours after they were last known to be well.2 The patients best served featured proximal middle-cerebral-artery or internal-carotid-artery occlusion, and a region of tissue that was ischemic but not yet infarcted.
This evolving treatment paradigm, while groundbreaking, requires new emergency department and collaborative workflows to identify appropriate stroke patients and activate the correct treatment pathway.
A New Stroke Protocol
Stanford University’s department of emergency medicine collaborated closely with other departments to develop a novel Stroke Code Extended protocol that expedites evaluation and treatment of patients with large-vessel
debilitating strokes that, prior to the protocol, would have limited treatment options. The protocol was crafted by a multidisciplinary team of stakeholders from the departments of neurology, emergency medicine, nursing, radiology, and hospital staff. We designed and implemented the new stroke code process using quality improvement principles, such as adherence to standard work, pre-existing protocol preservation, planned outcome measures, and widespread education. Mock code simulations provided iterative feedback before we launched the process.
The team created the protocol for patients presenting with stroke symptoms at 8–24 hours without changing the pre-existing code process for patients presenting before 8 hours (see Figure 1). Emergency physicians rapidly triage and activate all stroke codes if the patient presents as greater than or equal to 6 on the National Institutes of Health Stroke Scale (NIHSS). However, the new protocol excludes a bedside pharmacy evaluation and moves directly to alerting the stroke team to come to the patient’s bedside in the emergency department.